The Diagnostic Value of Serum MCP-1 Combined with OPN Detection for Early Renal Injury in Gout Patients

Haiying Chang,1 Jing Lv,1 Yinglin Zheng,2 Dongsheng Li,1 Yi Li2 1Rheumatology Department, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of China; 2Endocrinology Department, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of ChinaCorrespondence: Yi Li, Department of Endocrinology, Ganzhou People’s Hospital, No. 17 hongqi Avenue, Zhanggong District, Ganzhou, Jiangxi, 341000, People’s Republic of China, Tel +8618270976372, Email [email protected]: To explore the changes in serum Monocyte chemoattractant protein-1 (MCP-1) and Osteopontin (OPN) in gout patients and their diagnostic value for early renal injury.Methods: In this research, 174 gout patients (January 2022–October 2024) were divided into the early renal injury group (50 cases) and non-early renal injury group (124 cases). Additionally, 169 healthy individuals were included as controls. Clinical indicators such as serum creatinine, cystatin C (CysC), and GFR were recorded. MCP-1 and OPN levels were measured using ELISA. Pearson’s correlation was used to analyze relationships; Logit regression was applied to identify influencing factors, and ROC curves assessed diagnostic value, with AUC comparisons via Z-test.Results: Serum MCP-1 and OPN levels were significantly higher in the gout group compared to controls (P< 0.05) and further elevated in the early renal injury group (P< 0.05). MCP-1 and OPN correlated positively with creatinine and CysC and negatively with GFR (P< 0.05). Logit regression identified MCP-1 (OR: 2.765, 95% CI: 1.308– 5.846) and OPN (OR: 3.019, 95% CI: 1.468– 6.210) as independent risk factors (P< 0.05). The AUC for diagnosing early renal injury was 0.775 (MCP-1), 0.827 (OPN), and 0.938 (combined), with the combination significantly outperforming either marker alone (Z=3.075, 2.273, P< 0.05).Conclusion: The combination of serum MCP-1 and OPN in gout patients has a higher diagnostic value for early renal injury, it is obviously higher than the individual diagnosis of each indicator, and demonstrates significant clinical implications.Keywords: gout, early renal injury, monocyte chemoattractant protein-1, osteopontin, diagnosis

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-03-01
Primary Topic
Bone and Dental Protein Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Diagnostic Value of Serum MCP-1 Combined with OPN Detection for Early Renal Injury in Gout Patients

SHILAP Revista de lepidopterología
Bone and Dental Protein Studies
article

The Diagnostic Value of Serum MCP-1 Combined with OPN Detection for Early Renal Injury in Gout Patients

article en

Abstract

Haiying Chang,1 Jing Lv,1 Yinglin Zheng,2 Dongsheng Li,1 Yi Li2 1Rheumatology Department, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of China; 2Endocrinology Department, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of ChinaCorrespondence: Yi Li, Department of Endocrinology, Ganzhou People’s Hospital, No. 17 hongqi Avenue, Zhanggong District, Ganzhou, Jiangxi, 341000, People’s Republic of China, Tel +8618270976372, Email [email protected]: To explore the changes in serum Monocyte chemoattractant protein-1 (MCP-1) and Osteopontin (OPN) in gout patients and their diagnostic value for early renal injury.Methods: In this research, 174 gout patients (January 2022–October 2024) were divided into the early renal injury group (50 cases) and non-early renal injury group (124 cases). Additionally, 169 healthy individuals were included as controls. Clinical indicators such as serum creatinine, cystatin C (CysC), and GFR were recorded. MCP-1 and OPN levels were measured using ELISA. Pearson’s correlation was used to analyze relationships; Logit regression was applied to identify influencing factors, and ROC curves assessed diagnostic value, with AUC comparisons via Z-test.Results: Serum MCP-1 and OPN levels were significantly higher in the gout group compared to controls (P< 0.05) and further elevated in the early renal injury group (P< 0.05). MCP-1 and OPN correlated positively with creatinine and CysC and negatively with GFR (P< 0.05). Logit regression identified MCP-1 (OR: 2.765, 95% CI: 1.308– 5.846) and OPN (OR: 3.019, 95% CI: 1.468– 6.210) as independent risk factors (P< 0.05). The AUC for diagnosing early renal injury was 0.775 (MCP-1), 0.827 (OPN), and 0.938 (combined), with the combination significantly outperforming either marker alone (Z=3.075, 2.273, P< 0.05).Conclusion: The combination of serum MCP-1 and OPN in gout patients has a higher diagnostic value for early renal injury, it is obviously higher than the individual diagnosis of each indicator, and demonstrates significant clinical implications.Keywords: gout, early renal injury, monocyte chemoattractant protein-1, osteopontin, diagnosis

SHILAP Revista de lepidopterología
Good health and well-being
Openalex Percentile: Top 37%
Bone and Dental Protein Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.